Webinar: Application of ReproTracker in assessing developmental toxicity according to ICH S5
On the 12th of June, we hosted a webinar entitled “Application of ReproTracker in assessing developmental toxicity according to ICH S5”. During this webinar, we showcased how ReproTracker fits in as an alternative assay under ICH S5 (R3) guidelines and highlight a few cases that point out the added value of the assay over the conventional testing battery.
Please click here to request the webinar from us.
ReproTracker® is a state-of-the-art human stem cell-based in vitro assay that rapidly and reliably identifies developmental toxicity hazards of new drugs and chemicals. The assay captures the key cellular events of stem cell differentiation and early embryonic development. ReproTracker is used to investigate if compounds interfere with early embryonic development and the assay can quantitatively predict their teratogenic potential. ReproTracker can be used as an early-phase developmental toxicity screening platform, an alternative for animal-free teratogenicity testing of materials, or as a tool to extrapolate animal-derived results to humans.
